USPTO trademark

CERESITY

Under examinationUSPTOWord and designClass 9Class 35Class 42

"CERESITY" is a word and design mark owned by Ceresity Technologies, Inc., filed at the USPTO on September 17, 2026. It is under examination and covers classes 9, 35 and 42.

Get this data via the API
Official USPTO record
CERESITY trademark as filed
As filed with the USPTO
Status
Under examination
Since September 17, 2026
Filed
September 17, 2026
Registered
Not yet
Expires
Not recorded
Application no.
50113723
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word and design
3 classes
Ownership

Who owns CERESITY

The owner and representative on file with the office.

Owner

Ceresity Technologies, Inc.

Princeton, United States

Representative

Aliaksandr Lazouski

Lazouski IP LLC

Goods and services

What the mark covers

The products and services CERESITY is filed for, grouped by Nice class.

  • Downloadable computer software for analyzing clinical trial protocols, identifying clinical trial design and operational risks, generating recommendations, and comparing alternative clinical trial designs in the field of clinical research; Downloadable computer simulation software for modeling clinical trial designs and projected clinical trial outcomes; Downloadable computer software using machine learning for developing predictive models; Downloadable computer software for aggregating clinical trial data from disparate source systems and establishing data lineage and traceability to Clinical Data Interchange Standards Consortium (CDISC) data standards, namely, Study Data Tabulation Model (SDTM), Analysis Data Model (ADaM), and Clinical Data Acquisition Standards Harmonization (CDASH); Downloadable software for generating clinical data governance and metadata lineage reports

  • Business data analysis services in the field of clinical trials; Providing business intelligence services in the fields of medical devices, pharmaceuticals and the life sciences; Statistical analysis and reporting services for business purposes; Analyzing and compiling business data for clinical trial protocol optimization, operational risk assessment, clinical trial metadata governance, and data governance reporting purposes; Business consulting and management in the field of clinical trials, namely, providing information management services

  • Software as a service (SAAS) services, namely, hosting software for use by others for analyzing clinical trial protocols, identifying clinical trial design and operational risks, generating recommendations, and comparing alternative clinical trial designs in the field of clinical research; Providing online non-downloadable computer software platforms for analyzing clinical trial protocols, identifying clinical trial design and operational risks, generating evidence-backed recommendations, and comparing alternative clinical trial designs; Providing online non-downloadable software using machine learning for analyzing clinical trial protocol data, identifying clinical trial design and operational risks, and generating predictive metrics in the field of clinical research; Providing temporary use of online non-downloadable simulation software for modeling clinical trial designs and projected clinical trial outcomes; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence for creating complex data science analyses; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing temporary use of on-line non-downloadable software for aggregating and mapping clinical trial data from electronic data capture, laboratory, imaging, and other clinical source systems to Clinical Data Interchange Standards Consortium (CDISC) data standards; Software as a service (SAAS) services featuring software for managing clinical metadata governance, tracking data lineage, and performing automated quality control of clinical datasets; Providing on-line non-downloadable software for generating clinical data governance reports for use in regulatory submissions

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Application filing receipt mailed
  2. New application entered
FAQ

About CERESITY

Who owns the trademark "CERESITY"?

The USPTO trademark "CERESITY" (application 50113723) is owned by Ceresity Technologies, Inc.

What is the status of "CERESITY"?

Its status at the USPTO is: under examination.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull CERESITY and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_01a0b4a1-ffa0-756f-aab1-9c4562491515
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_01a0b4a1-ffa0-756f-aab1-9c4562491515",
  "object": "trademark",
  "mark_text": "CERESITY",
  "status": {
    "primary": "pending",
    "stage": "examining"
  },
  "office_code": "US",
  "application_number": "50113723",
  "filing_date": "2026-09-17",
  "nice_classes": [
    9,
    35,
    42
  ],
  "owners": [
    {
      "name": "Ceresity Technologies, Inc.",
      "entity_id": null
    }
  ]
}